Florida
Prescription drug spending and prescribing in Florida, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $21.5B for prescriptions written in Florida, the 3rd most of 52 states and territories, and 3.5% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $21.5B
- Medicaid drugs, 2025: $3.3B
- Opioid share of claims: 3.5%
- Life-science raises, 2 years: $1.1B
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Florida | United States | Difference |
|---|---|---|---|
| Opioids | 3.5% | 3.5% | 0% |
| Antibiotics | 5.2% | 4.4% | +17% |
| Antipsychotics | 1.5% | 1.7% | -16% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Florida's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Sildenafil Citrate | 3.4× | 217,595 |
| Ergocalciferol (Vitamin D2) | 3.3× | 440,308 |
| Folic Acid | 2.7× | 222,467 |
| Temazepam | 2.5× | 420,698 |
| Tadalafil | 2.4× | 68,756 |
| Ciclopirox Olamine | 2.4× | 92,764 |
| Ciclopirox | 2.2× | 150,688 |
| Ammonium Lactate | 2.2× | 211,229 |
| Gentamicin Sulfate | 2.2× | 66,096 |
| Cyanocobalamin (Vitamin B-12) | 2.1× | 56,791 |
Biggest Medicaid Drugs
What Florida's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
169 Form D raises by companies based in Florida in the last two years; the 10 largest. See all raises- SAB Biotherapeutics, Inc.$175M · Biotech · Aug 5, 2025
- Syncromune, Inc.$145M · Biotech · Dec 17, 2024
- ILIAD BIOTECHNOLOGIES, INC.$116M · Biotech · Feb 20, 2026
- EXUMA Biotech Corp.$70M · Biotech · Aug 20, 2026
- Concept Medical, Inc.$60M · Other health care · Apr 24, 2026
- CURADEL SURGICAL INNOVATIONS, INC.$50M · Biotech · Oct 13, 2026
- InspireMD, Inc.$40M · Other health care · Aug 4, 2025
- Spiro Medical Inc.$37M · Other health care · Jan 5, 2026
- Relation Therapeutics Inc.$36M · Biotech · Dec 9, 2025
- Smith Medical Holdings Inc.$23M · Other health care · Apr 30, 2026
State Attorney General Health-Care Cases
Antitrust cases Florida joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Attorney General v. Florida Cancer Specialists and Research Institute, LLC (Fl. Cir. Ct., Leon Cty., Apr. 30, 2020)2020 · Settlement
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG